ACRO’s alliances: Advancing the clinical research enterprise around the world

By working together with related groups, ACRO encourages cross-industry cooperation, promotes ACRO’s policy positions and create new opportunities for our members. ACRO’s alliances include:

Advocacy and Education Coalitions

  • The Alliance for a Stronger FDA  works for increased appropriations to strengthen the FDA.
  • The Alliance for Regenerative Medicine (ARM) educates key policymakers about the potential of regenerative medicine and advocates for favorable public policies to advance the field. John Lewis serves on the Board.
  • The Alliance for Safe Biologic Medicines (ASBM) works to ensure patient safety is at the forefront of the biosimilar medicines policy discussion. John Lewis serves in the Steering Committee.
  • The Center for Information and Study on Clinical Research Participation (CISCRP) is committed to educating and informing the public, patients, medical and research communities, the media and policymakers about clinical research and the role each party plays in the process.
  • The Coalition of Small Business Innovators supports the modernization of the current U.S. tax code through recognizing and promoting pre-revenue small business innovation as fundamental to the long-term growth of the U.S. economy.
  • Friends of Cancer Research is a non-profit cancer research think tank and advocacy organization based in Washington, DC.
  • The Healthcare Leadership Council (HLC) is the exclusive forum for the nation’s health care leaders to jointly develop policies, plans, and programs to achieve their vision of a 21st century system that makes affordable, high-quality care accessible to all Americans. ACRO participates actively in the HLC Confidentiality Coalition, which aims to facilitate the use of health data for research and treatment purposes, while ensuring the security and confidentiality of medical information.
  • The International Pharmaceutical Privacy Consortium (IPPC) addresses worldwide data privacy and security issues, assessing and minimizing risks, and creating practical standards for industry performance.
  • The European Forum for Good Clinical Practice (EFGCP) is a non-profit organization established by and for individuals with a professional involvement in the conduct of biomedical research.
  • The Partnership to Improve Patient Care advances proposals for comparative effectiveness research (CER) that give providers and patients the information they need, improving health care quality and supporting continued medical progress. John Lewis serves on the Steering Committee.
  • Research!America  is the nation’s largest not-for-profit public education and advocacy alliance working to make research to improve health a higher national priority.
  • The Society for Clinical Research Sites is the first trade association established to represent the global clinical research sites, providing the sites a voice and a community.
  • The U.S. Chamber of Commerce/U.S. India Business Council represents the interests of more than three million businesses of all sizes, sectors, and regions, as well as state and local chambers and industry associations.
  • The R&D Credit Coalition is a group of more than 100 trade and professional associations along with companies of all sizes that collectively represent millions of American workers engaged in U.S.-based research throughout major sectors of the U.S. economy. John Lewis serves on the Steering Committee.

Government-Industry Collaborations

Standards-Setting Organizations

  • The Clinical Data Interchange Standards Consortium (CDISC) is a global, open, multidisciplinary, non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data and metadata. Doug Peddicord serves on the Board of Directors.
  • Clinical Data Acquisition Standards Harmonization (CDASH) is a CDISC-led initiative to develop content standards for basic global data collection fields that support clinical research studies.

ACRO works with government agencies around the world to advance clinical research

Scroll to Top